Histocompatibility antigens and genetic control of the immune response in guinea pigs. III. Specific inhibition of antigen-induced lymphocyte proliferation by strain-specific anti-idiotypic antibodies by unknown
HISTOCOMPATIBILITY ANTIGENS AND  GENETIC 
CONTROL  OF  THE  IMMUNE  RESPONSE  IN  GUINEA  PIGS 
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by Strain-Specific Anti-Idiotypic Antibodies* 
By A.  F.  GECZY, C.  L.  GECZY, AND A.  L.  DE WECK 
(From the Institute for Clinical Immunology, Inselspital, Bern, Switzerland) 
Immunization with  lymphoid  cells  among various  (2  ×  13)F2 hybrid  guinea  pigs 
resulted in the production of antisera which could specifically block antigen-induced T- 
cell proliferation in vitro (1). The donor lymphoid cells and the recipient animals were 
chosen from F2 hybrid guinea pigs of identical  (2  ×  13) histocompatibility type but in 
which the  responsiveness  to  low doses of aspirin  anhydride  (ASAN), 1 penicilloylated 
bovine IgG (BPO-BGG),  or multichain copolymer poly-L-(Tyr,  Glu)-poly-DL-Ala-poly-L- 
Lys [(T,G)-A--L] had segregated independently of each other. The response to low doses of 
these three antigens appears linked to the strain  13 major histocompatibility complex 
(MHC) but requires an additional gene(s) not linked to the MHC. Strain 2 guinea pigs 
only respond to high doses of these antigens (1). It was concluded from these studies that 
the antisera raised with lymphoid cells of low dose-responder (2  × 13)F~ hybrids contain 
antibodies which are not directed against Ir gene products associated with the strain 13 
MHC  but  against  at  least  three  separate  recognition structures  or  receptors  on  the 
lymphoid cell membrane. Preliminary experiments, involving the passage of BPO-BGG 
antireceptor antisera (anti-RBeo_B~) through an immunoadsorbent column prepared with 
purified antibody  (anti-BPO-BGG) suggested that the  anti-R serum was not directed 
against  immunoglobulin idiotypes.  However,  since  this  experiment  was  not entirely 
conclusive, we undertook further studies aimed at answering the question whether our 
anti-R sera against recognition structures are, in fact, anti-idiotypes. 
Immunoadsorbent  column-purified  anti-BPO-BGG,  raised  in  strain  2  and 
strain  13 guinea pigs, was used to immunize both strain 2 and 13 animals and 
the resultant antisera tested for their ability to inhibit the BPO-BGG-induced T- 
cell  proliferation  of  cells  from  high  dose-responder  strain  2  and  low  dose- 
responder strain 13 guinea pigs. In this paper we examine some of the properties 
of these antisera and compare them with an antireceptor serum  (anti-RBm_BGc) 
* This work was supported in part by the Swiss National Foundation for Scientific Research. 
Abbreviations  used  in  this paper:  ~ strain 2 BPO-BGG, anti-idiotypic antibodies raised  in 
strain 2 against strain 2 anti-BPO-BGG; ~ strain 13 BPO-BGG, anti-idiotypic antibodies raised in 
strain  13 against  strain  13 anti-BPO-BGG; ASAN, acetylsalicylic acid anhydride;  ASP-OVA, 
aspiryl  ovalbumin; BPO-BGG, penicilloylated  bovine IgG; CFA, complete Freund's  adjuvant; 
DMSO, dimethyl sulfoxide; GL, copolymer poly(L Glu, Lys); GT, copolymer poly(L Glu, Tyr); M- 
199, medium 199; MHC, major histocompatibility complex; PBS, 0.01 M phosphate-buffered 0.9% 
NaC1 (pH 7.4); PEL, peritoneal  exudate lymphocytes; PHA, phytohemagglutinin;  R, receptors; 
TBS, 0.02 M Tris-buffered 0.9% NaCl  (pH 8.2); (T,G)-A--L multichain  copolymer poly-L-(Tyr, 
Glu)-poly-DL-Ala-poly-L-Lys. 
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which had been raised by immunizing with lymphoid cells from an F2 hybrid 
which lacked one of the genes required for the full expression of high responsive- 
ness to BPO-BGG (1). We will provide evidence that in vitro T-cell proliferation 
induced by BPO-BGG may be specifically inhibited by strain-specific antibodies 
probably directed against cell surface-associated immunoglobulin idiotypes. 
Materials and Methods 
Animals.  Guinea  pigs  of strain  2  and  13  (400-600  g)  were  obtained  from  the Institut  ffir 
biologisch-medizinische Forschung AG,  Fiillinsdorf, Switzerland;  their phenotype  was checked 
before use by lymphocytotoxicity typing (see below). 
Antigens and Immunization of Guinea Pigs.  In general,  strain  2 and  strain  13 guinea pigs 
were  immunized  simultaneously  with  all  antigens  (high  dose  immunization  schedule).  5  mg 
ASAN (Chemische Fabrik Aubing,  Miinchen,  Germany) were injected intradermally in 0.1 ml 
dimethyl sulfoxide (DMSO) on days 0, 4, and 8. BPO-BGG (100/~g) and (T,G)-A--L (5 rag; Miles- 
Yeda,  Rehovot,  Israel) dissolved in phosphate-buffered  saline  (PBS),  0.01  M, pH 7.4  and  Tris- 
buffered saline  (TBS),  0.02  M,  pH 8.2,  respectively, were emulsified with an equal volume of 
complete Freund's adjuvant  (CFA, Difco Laboratories,  Detroit,  Mich.).  On day 0,  each animal 
received 0.8 ml of emulsion divided equally among the four foot pads. In addition, strain 2 animals 
were also immunized with a copelymer of L-glutamic acid (60%) and L-lysine (40%) (GL). Dinitro- 
phenyl-GL (DNPrGL) was kindly supplied by Dr. I. Green, NIH, Bethesda (Md.). The subscript 
refers to the average number of DNP groups per molecule. Strain 13 animals were injected with a 
copolymer of t,-glutamic acid  (50%)  and  L-tyrosine  (50%)  (GT;  Miles Laboratories,  Inc.,  Miles 
Research  Div.,  Kankakee,  Ill.).  Solutions of DNPT-GL  and  GT in  0.01  M  PBS,  pH  7.4,  were 
emulsified with an equal volume of CFA. Animals were immunized with 100 pg of DNPT-GL or 500 
~zg of GT subcutaneously in multiple sites in the nuchal skin or thigh. In one series of experiments 
in which the influence ofanti-idiotypic sera on cells from low dose- and high dose-immunized (2 × 
13)Fz guinea pigs was compared,  the following low dose immunization  schedule was followed: 
ASAN (100 ~l of a  20% solution in DMSO) was applied epicutaneously on days 0, 4, and 8. BPO- 
BGG (10 ~g in 100 izl PBS) was injected intradermally on days 0, 4, 6, 8, and 10. (T,G)-A--L (500/~g 
in 100 ~l TBS) was given intradermally on days 0, 4, 6, and 8, all without adjuvant. 
Detection of  Contact and Delayed-Type Skin Hypersensitivity.  In all cases the flank was shaved 
with an electric clipper a few hours before testing. The increase in skin thickness at the reaction 
site  was  measured  24  h  after  testing  with  a  caliper  CSchnelltaster";  Kroeplin,  SchOchtern, 
Germany). Increase in skin thickness of more than 0.6 mm has been shown (2) to be statistically 
significant at the P  <  0.05 level and reactions above that level were considered positive. 
ASAN.  25 /zl of a 0.4% and 4.0% (wt/vol) ASAN solution and 0.05 ml of a  10.0% (wt/vol) ASAN 
solution in acetone-almond oil (1:1, vol/vol) were applied with a pipette on stamped round 2 cm  2 
surfaces of the flank. Reactions were read at 24 h and evaluated according to the following scale: 0, 
no reaction; 0.5,  disseminated faint red papules over the test area;  1.0,  confluent erythema; 2.0, 
marked erythema and slight edema; and 3.0, deep erythema, edema, and necrosis. 
BPO-BGG,  (T,G)-A-'L,  DNPT°GL,  AND GT.  Delayed skin reactivity was assessed by the intrader- 
real injection into the shaved flank of 1 and 10 $zg of BPO-BGG in 100 tzl of PBS (0.01 M, pH 7.4); 1 
and 25 ~g of  (T,G)-A--L  in 100 ~tl  of  TBS (0.02  M, pH 8.2);  and 10  and 50 ~tg  of  DNPT-GL and GT 
each in 100/zl  of  PBS. 
Production  of  Antisera.  Strain 13 antistrain  2 serum and strain  2 antistrain  13 serum were 
prepared by cross-immunizing animals of  these strains  with a homogenate of  lymph node and 
spleen cells  as previously  described (1).  Preparation of  an antiserum against specific  recognition 
structures  or  "receptors"  for  BPO-BGG  (anti-Rs~)-Bcc)  has  already been  described  (1).  Briefly,  (2 × 
13)  siblings  from F2  hybrid  guinea  pigs  were cross-immunized  with  lymphoid cells.  Thus, an anti- 
Rspo-BoG  serum could  be  raised  by  the  immunization of  a (2 × 13)  ASAN +  BPO-BGG-  (T,G)-A--L  + 
guinea pig with (2 × 13)  ASAN-  BPO-BGG + (T,G)-A--L- lymphoid cells. 
Antisera against strain  2 and strain  13  anti-BPO-BGG were  prepared  as  follows:  Firstly,  anti- 
BPO-BGG  antibodies were raised by immunizing strain  2 and strain 13 guinea pigs with 1 mg 
BPO-BGG  in CFA, equally distributed  in the four foot  pads, and 2 wk later  boosted with 1 mg 
BPO-BGG  in  0.9%  NaCl, administered  intracutaneously in  multiple  sites  in  the nuchal  skin.  2  wk 228  GUINEA  PIG  STRAIN-SPECIFIC  ANTI-IDIOTYPIC  ANTIBODIES 
later, the sera from such animals were passed over a BPO-BGG-bearing polyacrylamide immuno- 
adsorbent column prepared as previously described (3).  The anti-BPO-BGG antibodies bound to 
the column were eluted with glycine-HC1 buffer, 0.1 M, pH  2.5,  containing 0.9% NaC1 and the 
eluate neutralized with 1 M Tris. Antibody concentration was determined by the absorbance at 278 
nm in neutral solution using an extinction coefficient (E~:m) of 14.0 as described by Eisen et al. (4) 
for anti-DNP antibodies. 
The immune anti-BPO-BGG antibodies were then used as immunogens for the sensitization of 
four strain 2 and four strain 13 guinea pigs. Two strain 2 guinea pigs received 2 mg of anti-BPO- 
BGG (raised in strain 2) and the other two strain 2 animals were given the same amount of anti- 
BPO-BGG derived from strain 13 animals. Similarly, two strain 13 guinea pigs received swain 2 
anti-BPO-BGG while two other strain 13 animals were immunized with anti-BPO-BGG raised in 
strain 13 guinea pigs. The anti-BPO-BGG was injected in 0.8 ml CFA, equally distributed among 
the four foot pads.  2 wk  later the animals received a  boost of 1 mg of anti-BPO-BGG in  CFA 
(subcutaneously in multiple sites in the nuchal skin) and a further injection (200  tzg anti-BPO- 
BGG intradermally) 10 days after the first boost. All animals were exsanguinated 2 wk after the 
last injection, the sera sterilized by Millipore filtration, and stored at  -20°C. 
Cytotoxicity Testing.  The details of this test have previously been reported (1). The percentage 
of maximum '~Cr released was calculated as follows: 
Radioactivity released by antiserum dilution 
~Cr release %  =  100 ×  -  radioactivity released in absence of antiserum 
Radioactivity released by frozen-thawed cells 
-  radioactivity released in absence of antiserum. 
Absorption  ofAnti-ldiotypic Antisera.  Antisera were mixed with an equal volume of packed 
lymph node and spleen cells (approximately I0  '~ cells/ml of serum) for 4 h at 4°C.  Each antiserum 
was absorbed at least three times. The absorbed antisera were centrifuged at 10,000 rpm for 30 rain 
and sterilized by Millipore filtration. 
Cell Preparation 
LYMPH NODE CZLLS.  The regional lymph nodes were removed, freed as far as possible from fat, 
and cell suspensions prepared by teasing with scissors and forceps and then by pressing the lymph 
node fragments through no.  60 wire  screens (Haska,  Bern,  Switzerland).  The cell suspensions 
were then washed twice with medium 199 (M-199). The cell population was composed of over 95% 
lymphocytes and about 5% macrophages. For the assay of antigen-induced lymphocyte prolifera- 
tion in the presence of alloantisera, lymphocyte suspensions (20  x  10~/ml) were incubated with 
either 100  ~g of DNPT-GL and GT or 400/zg of aspiryl-ovalbumin (ASP-OVA), BPO-BGG,  and 
(T,G)-A--L/ml of M-199 containing 10% heat-inactivated fetal calf serum. A portion of the cells was 
also incubated with 10  /zg phytohemagglutinin (PHA)/ml of M-199. The cells were pulsed with 
antigen for 30 min at 37°C.  Since ASAN is insoluble in water, ASP-OVA prepared as previously 
described by de Weck (5) was used in the in vitro studies. The cells were washed three times with 
M-199 and then cultured at a  cell concentration of 2  ×  10  ~ cells/ml in polystyrene tubes (Nunc, 
Roskilde, Denmark) at 37°C for 72 h, adding either I% normal guinea pig serum or 1% guinea pig 
antiserum supplemented with 9% heat-inactivated fetal calf serum. 18 h before the termination of 
the cultures,  1 pCi of tritiated thymidine (sp act, 5 Ci/mmol; The Radiochemical Centre, Amer- 
sham, Great Britain) was added to each vial. The cells were harvested with a multiple cell culture 
harvester (Skatron, Lierbyen, Norway), and the radioactivity was measured in a Beckman liquid 
scintillation counter (Beckman Instruments, Inc., Fullerton, Calif.). The results were expressed 
as total counts per minute per culture. 
PERITONEAL EXUDATE LYMPHOCYTES (PEL).  Guinea pigs were injected intraperitoneally with 30 
ml of sterile paraffin oil to induce a peritoneal exudate. 4 days later, the animals were killed by 
cardiac puncture and the peritoneal cavity washed with 200 ml of Hanks' balanced salt solution 
containing 5 U/ml of preservative-free heparin (Hoffmann-La Roche, Basel, Switzerland). Perito- 
neal exudate cells were washed three times in Hanks' solution to remove oil and finally suspended 
in RPMI 1640 (Microbiological Associates, Bethesda, Md.) containing 100 U penicillin and 100 ~g 
of streptomycin/ml and 2 mM glutamine. The lymphocytes were separated from the whole exudate 
cell  population  by  passage  over  a  column  of cotton  wool  (Schaffhauser  Watte,  Schaffhausen, A.  F.  GECZY,  C.  L.  GECZY,  AND  A.  L.  de  WECK  229 
Switzerland)  packed loosely in  a  50 ml plastic  syringe.  The population  of cells after column 
purification consisted of 80-90% lymphocytes with a viability of over 95% as measured by trypan 
blue exclusion. About 90% of the PEL formed rosettes  with rabbit  red blood cells as previously 
described (1, 3). The assay of antigen-induced  proliferation  in the presence of antisera  was the 
same as described for lymph node cells. 
Preparation of Sepharose Immunoadsorbents.  Sepharose  4B  (Pharmacia  Fine  Chemicals, 
Ltd.,  Uppsala,  Sweden) was activated  with  cyanogen bromide and coupled with  protein  [40% 
(NH4)2SO4 fractions of  guinea pig sera; Ig fractions] as described in the Pharmacia Fine Chemicals 
Instruction Manual (Affinity Chromatography, Principles and Methods). Each gram of Sepharose 
bound about 5 mg of protein. 
Radioimmunoassay.  Untreated  Sepharose  4B  and  activated  Sepharose  bearing  a  normal 
guinea pig Ig fraction or Ig fractions prepared from strain 2 antistrain 2 anti-BPO-BGG (a strain 2 
BPO-BGG) and strain 13 antistrain 13 anti-BPO-BGG (~ strain 13 BPO-BGG) sera, were equili- 
brated with Phadebas RAST buffer solution, pH 7.4 (Pharmacia Fine Chemicals, Ltd.), containing 
2 ml Tween 20/100 ml buffer for 2 h before use. 100 t~l of Sepharose (100 mg wet weight) were 
incubated with 5 ~g of J2'~I-labeled antigen  (Ig fractions of strain 2 and strain 13 anti-BPO-BGG 
were labeled with  iodine-125 according to the method of Hunter and Greenwood (6), in 100 t~l 
RAST buffer solution in the presence of PBS or unlabeled antigen  (5 t~g in 100 ill PBS) for 16 h at 
room temperature.  The Sepharose was then washed 10 times with 0.9% NaC1 (containing 5 ml 
Tween 20/liter) and the radioactivity  bound to the Sepharose beads determined  in a LKB 8000 
gamma counter (LKB Produkter,  Stockholm, Sweden). 
Sephadex Chromatography.  2 ml of antiserum (~ strain  2 BPO-BGG and a strain  13 BPO- 
BGG) were chromatographed on Sephadex G-200 (90 x 2.6 cm) which had been equilibrated with 
TBS. The peak tubes from the 19S, 7S, and 4S regions were tested for their capacity to inhibit 
antigen-induced lymphocyte proliferation. 
Results 
Relationship  between Histocompatibility  Type and Responsiveness  to Anti- 
gens.  We have previously shown (1) that strain 13 and (2  x  13)F1 guinea pigs 
respond  to  low  doses  of ASAN,  BPO-BGG,  and  (T,G)-A--L  (as  assessed  by 
delayed skin reactivity and in vitro lymphocyte stimulation),  whereas strain 2 
animals fail to respond. However upon stronger and more prolonged immuno- 
genic stimuli [i.e. immunization with 10- to 20-fold higher doses ofASAN, BPO- 
BGG, and (T,G)-A--L than that required for strain 13 animals] strain 2 animals 
can also be sensitized to these three antigens.  In the present study we immu- 
nized strain 2 and strain 13 animals with high doses of ASAN, BPO-BGG, and 
(T,G)-A--L to ensure that all strain 2 animals would give strong delayed skin 
responses when tested  with these  antigens 3 wk after immunization.  In addi- 
tion, all strain 2 animals responded to DNP-GL but not to GT, whereas strain 13 
guinea pigs showed strong delayed skin reactivity to GT but failed to react to 
DNP-GL;  (2  x  13)F1 responded  to  both  GT  and  DNP-GL.  Responsiveness  to 
DNP-GL and GT is known to be linked to the strain 2 and strain 13 haplotype, 
respectively (7,  8). 
Inhibition of Lymphocyte Stimulation  by Anti-Idiotypic Antisera Raised in 
Strain 2 and Strain 13 Guinea Pigs.  As described in the Material and Methods 
and Fig. 1, antisera were raised in strain 2 and 13 guinea pigs using as antigen 
anti-BPO-BGG antibodies from strain 2 or 13, purified by immunoadsorption on 
polyacrylamide columns bearing BPO-BGG. The following four antisera  were 
investigated for their  ability to inhibit  antigen-induced lymphocyte prolifera- 
tion: ~  strain  2  BPO-BGG, ~  strain  13 BPO-BGG, strain  2 antistrain  13  anti- 
BPO-BGG,  and  strain  13  antistrain  2  anti-BPO-BGG.  The first two antisera, 230  GUINEA  PIG  STRAIN-SPECIFIC  ANTI-IDIOTYPIC  ANTIBODIES 
BPO-BGG  in ~A 
Strain ~§train  13 
guine@  pig  9uinea  pig 
Immunoadsor!,ent  columLpurified  Immunoadsorvlnt  co[u:n-purified 
strain 2  anti-3P3-BG~  drain 13 anti-BPs-BSb 
Imunize with 
anti-~PO-BGG  in 
CF. 
Strai  n  13  ~train~2J~train  13 
antidrain 2  antistrain  2  antidrain  13  antistrain  13 
anti-BPO-BGG  anti-BPO-BGG  anti-BPO-B~G  anti-BPO-~GG 
FIG.  1.  Scheme  for the  production  of anti-idiotypic  sera  in  strain  2  and strain  13  guinea 
pigs. 
TABLE  I 
Inhibition of Lymphocyte Proliferation by Anti-R spo_~vG and Anti-Idiotypic  Sera in Primed 
High Dose-Immunized (2  x 13)F~ Lymph Node Cells 
Guinea pig serum added* 
Stimulant  b Strain  b Strain  Strain 2  Strain 13 
Normal  13 Anti-2  2 Anti-13  Anti-I~,_~(a~  2 BPO-BGG  13 BPO-BGG  antistrain 13  antistrain 2 
anti.BPO-BGG  anti-BPO-BGG 
NIL  4685  378  509  389  462  728  499  603 
PHA  48,632  42,432  40,081  39,805  41,182  38,980  42,508  43,087 
DNP-GL  33,472  309  30,826  34,820  35,487  30,800  36,087  30,627 
GT  30,466  29,832  46_..77  29,806  28,632  32,087  29,608  29,783 
ASP-OVA  40,863  35,678  68~8  37,874  42,500  38,432  38,873  39,975 
BI~)-BGG  39,508  36,444  797  49_.99  5_..~  6~  37,050  37,003 
(T,G)-A--L  36,482  32,473  669  34,343  35,486  33,432  32,857  35,626 
* Final concentration  of serum in culture  was 1%. 
$ Results are expressed  as mean counts per minute per culture.  Each result represents  the mean of three cultures; significantly  depressed 
results are underlined. 
presumed  to  be  directed  against  strain  2  and  strain  13  anti-idiotypes,  were 
designated  as  ~.  None  of the  four  sera  appeared  to  contain  lymphocytotoxic 
antibodies to currently known alloantigens coded for by the B  and I  regions of 
the guinea pig MHC, as determined by the slCr-release assay on strain 13 and 
strain 2 lymphocytes  (results not shown). Table I illustrates that primed (2  x 
13)F1 lymph node cells from high dose-immunized guinea pigs pulsed with PHA, 
DNP-GL,  GT,  ASP-OVA,  BPO-BGG,  or  (T,G)-A--L  and then  cultured  in the 
presence of normal guinea pig serum for 72 h  are stimulated as measured by 
tritiated thymidine incorporation into their DNA. When a portion of these cells 
is cultivated in the presence of 13 anti-2 serum there is a marked inhibition of 
the DNP-GL-induced  stimulation while the responses of cells pulsed with the 
other antigens  are  unaffected  (1).  In the presence of 2 anti-13  serum the  GT A.  F.  GECZY,  C.  L.  GECZY,  AND  A.  L.  de  WECK  231 
TABLE  II 
Comparison  of the Effect of Anti-Idiotypic and Anti-RBpo-BcG Sera on the In Vitro 
Proliferative Response of  Lymph Node Cells from High Dose- and Low Dose-Immunized 
(2 × 13)F~ Guinea Pigs 
Stimulant 
Guinea pig serum added* 
a Strain  a Strain 
Normal  2 BPO-BGG  13 BPO-BGG  Anti-l~po-BGG 
High dose immunized 
NIL  262*  459  424  448 
PHA  102,949  111,869  78,975  126,043 
ASP-OVA  100,793  99,831  93,031  120,701 
BPO-BGG  90,423  2__~  21___55  62._.44 
(T,G)-A--L  100,772  108,916  102,487  109,064 
Low dose immunized 
NIL  235  289  293  284 
PHA  121,606  140,059  134,868  119,632 
ASP-OVA  113,101  130,974  87,193  71,286 
BPO-BGG  82,592  111,350  350  310 
(T,G)-A--L  100,200  100,927  100,670  98,501 
* See footnote  to Table I. 
response is suppressed as well as the proliferative responses of cells stimulated 
with ASP-OVA,  BPO-BGG,  and  (T,G)-A--L (7,  9).  By contrast,  anti-RBpo-aGC 
serum  (raised by immunizing with lymphoid cells among (2  x  13)F2 hybrid 
guinea pigs), ~ strain 2 BPO-BGG as well as ~ strain 13 BPO-BGG sera totally 
suppress the proliferative response only of BPO-BGG-pulsed cells but do not 
affect the response to any of the other antigens. On the other hand, antisera 
raised in strain 2 and strain 13 guinea pigs against anti-BPO-BGG antibody of 
the allogeneic strain (i.e., strain 2 antistrain 13 anti-BPO-BGG and strain 13 
antistrain  2  anti-BPO-BGG)  failed  to  interfere  with  the  in  vitro  reactivity 
induced by any of the antigens. 
In  contrast  to  the  situation  with  2  ×  13  lymphoid cells  from high  dose- 
immunized animals, cells from low dose-immunized animals can only be  in- 
hibited by ~ strain 13 BPO-BGG serum but not by ~ strain 2 BPO-BGG (Table II) 
suggesting that high dose immunization is required to induce the synthesis of 
the appropriate  strain 2-specific idiotype recognition structures on the mem- 
brane of primed (2  x  13)F1 cells. 
The  Failure  of d  Strain  2  BPO-BGG  and  d  Strain  13  BPO-BGG  Sera  to 
Suppress  Lymphocyte  Activation  of  Cells  Derived  from  the  Allogeneic 
Strain.  To  investigate the  possibility that the  ~  strain  2  BPO-BGG  and 
strain 13 BPO-BGG sera may be directed against strain-specific idiotypes, the 
capacity of these  antisera  to  inhibit  T-cell  activation in  the  syngeneic and 
allogeneic  strain  was  studied.  Furthermore,  to  ensure  that  the  stimulation 
observed in this system was due to tritiated thymidine incorporation into the 
DNA ofT cells, the influence of  the antisera on PEL (which are composed almost 
entirely of thymus-derived cells [10]) from primed strain 2 and strain 13 guinea 
pigs was also investigated. 
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TABLE III 
Inhibition of T-Cell Proliferation by Anti-Idiotypic Sera in Primed Strain 2 PEL Capable o] 
Responding to ASP-OVA, BOP-BGG, and (T,G)-A--L 
Guinea pig serum added* 
Stimulant 
Strain  a Strain 
2 BPO-BGG  2 BPO-BGG  Strain  ~ Strain 
Normal  Anti-Rapo_~  2 BPO-BGG  13 BPO-BGG absorbed  with  absorbed  with 
strain 13  strain 2 
cells  cells 
NIL  161"  152  94  151  118  151 
PHA  108,031  98,772  94,818  64,024  86,111  104,037 
ASP-OVA  54,826  69,037  50,933  57,068  74,859  86,818 
BPO-BGG  110,851  75,105  140  70,402  154  86,468 
(T,G)-A--L  101,148  68,934  79,059  77,889  90,542  96,934 
* See footnote  to Table I. 
BGG-induced T-cell proliferation of strain 2 cells which are capable of respond- 
ing to all three antigens. Antiserum ~ strain 13 BPO-BGG also does not suppress 
the in vitro BPO-BGG response.  By contrast, the corresponding antiserum 
strain 2 BPO-BGG specifically suppresses T-cell activation of BPO-BGG-pulsed 
immune strain  2  cells.  In  addition,  immune  BPO-BGG  ÷ cells  from strain  2 
guinea pigs are capable of absorbing the inhibitory activity from ~ strain 2 BPO- 
BGG serum, while immune BPO-BGG  ÷ cells from strain 13 animals fail to do so. 
By contrast, cells from nonimmunized animals failed to absorb the inhibitory 
activity from the two strain-specific antisera (results not shown). 
Conversely, BPO-BGG-pulsed PEL from primed strain  13  guinea pigs  can 
only be inhibited by an antiserum against anti-BPO-BGG raised in the isogeneic 
strain  (~ strain 13  BPO-BGG) but not by ~ strain 2 BPO-BGG, raised in the 
allogeneic strain  (Table IV).  In addition, anti-RBpo-B~c can also suppress  the 
BPO-BGG response of strain 13 but not of strain 2 cells. It is clear, therefore, 
that the antisera (~ strain 2 BPO-BGG and ~ strain 13 BPO-BGG) must interact 
with  some  gene  product(s)  characteristic of the  isogeneic strain  in  order  to 
suppress antigen-induced T-cell proliferation in vitro. It seems likely that the 
antisera are directed against membrane-associated strain-specific immunoglob- 
ulin idiotypes which may function as T-cell antigen receptors. 
The Inhibitory Activity  of d Strain 13 BPO-BGG Can Only Be Absorbed by 
BPO-BGG ÷ Cells.  In addition to strain specificity, the anti-idiotypic serum, 
raised in a strain 13 combination against "receptors" for BPO-BGG, is specific 
for BPO-BGG-pulsed cells and does not suppress either ASP-OVA- or (T,G)-A-- 
L-induced lymphocyte proliferation (Tables I, III, and IV). The data in Table V 
lend further support to the specificity of the antiserum: inhibitory activity can 
only be  removed by absorption  with cells from strain  13  guinea pigs  which 
respond to low doses of BPO-BGG and not by cells from the occasional strain 13 
animals which fail to respond to BPO-BGG but give strong responses to ASAN 
and (T,G)-A--L. 
The Inhibitory Activity of the Anti-Idiotypic Sera is Associated with the 19S 
Fraction.  2  ml  of ~  strain  13  BPO-BGG  serum  were  chromatographed  on A.  F.  GECZY,  C.  L.  GECZY,  AND  A.  L.  de  WECK  233 
TABLE  IV 
Inhibition ofT-Cell Proliferation by Anti-R  spo_~GG and AntioIdiotypic Sera in Primed Strain 13 
PEL Capable of Responding to ASP-OVA, BPO-BGG, and (T,G)-A--L 
Guinea pig serum added* 
Stimulant 
a Strain  a Strain 
13 BPO-BGG  13 BPO-BGG 
a Strain  a Strain 
Normal  Anti-RBPo-SGC  2 BPO-BGG  13 BPO-BGG  absorbed  with  absorbed with 
strain 13  strain  2 
cells  cells 
NIL  555*  830  1,156  778  356  693 
PHA  113 ;442  89,423  107,980  65,000  94,673  96,527 
ASP-OVA  97,673  81,353  89,218  86,124  79,419  77,379 
BPO-BGG  93,525  1,129  87,926  1,348  80,687  91___66 
(T,G)-A--L  105,458  68,904  96,712  86,771  86,084  91,979 
* See footnote  to Table I. 
TABLE V 
The Absorption  of Inhibitory Activity from d Strain 13 BPO-BGG Serum with BPO- 
BGG +  Cells 
Guinea pig serum added* 
Stimulant 
NIL  PHA  ASP-OVA  BPO-BGG  (T,G)-A--L 
Normal  1,042"  163,539  140,443  127,165  181,877 
Strain 13 BPO-BGG  1,214  177,546  129,221  1,093  175,654 
Strain 13 BPO-BGG absorbed with ASAN  +  1,039  148,832  199,962  1,282  188,439 
BPO-BGG- (T,G)-A--L  cells 
/l Strain 13 BPO-BGG absorbed with ASAN-  1,157  236,355  212,217  167,704  216,369 
BPO-BGG+ (T,G)-A--L- cells 
Strain 13 BPO-BGG absorbed with &SAN-  1,155  191,444  195,746  1,164  192,056 
BPO-BGG- (T,G)-A--L  + cells 
* See footnote to Table I. 
Sephadex G-200,  and the fractions eluted with TBS.  The peak tubes from the 
19S, 7S,  and 4S fractions were tested for their capacity to inhibit BPO-BGG- 
induced lymphocyte proliferation. 
The antigen-pulsed cells were incubated with 1% normal guinea pig serum 
and 9% heat-inactivated fetal calf serum together with either 0.1 ml of TBS or 
0.1 ml of the appropriate 19S, 7S,  or 4S Sephadex G200 column fractions. The 
absorbances at 278 nm of the peak tubes of the various fractions were as follows: 
1.1  (19S); 0.7  (7S); and 1.0 (4S). 
The data in Table VI show that the undiluted 19S fraction of ~ strain 13 BPO- 
BGG totally inhibits the in vitro BPO-BGG response but does not affect (T,G)- 
A--L-induced in vitro proliferation. The 7S and 4S fraction, on the other hand, 
suppress  BPO-BGG reactivity by only 30%. At a  1/20 dilution only the  19S 
fraction inhibits the in vitro BPO-BGG response. It appears, therefore, that the 
inhibitory activity of the anti-idiotypic serum is primarily associated with the 
19S fraction. Similar data were obtained with a strain 2 BPO-BGG which had 
been chromatographed on Sephadex G-200 (results not shown). 
The Relative Affinity of Strain 2  and Strain 13 Anti-Idiotype Sera for Isoge- 
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TABLE  VI 
The Inhibition of BPO-BGG-Induced  Proliferation  of Primed Strain 13 
Lymph Node Cells by the 19S Fraction of d Strain 13 BPO-BGG Serum 
Stimulant  Serum fraction  Fraction dilution  Inhibition* 
% 
BPO-BGG  19S  None  100 
19S  1/20  72 
(T,G)-A--L  19S  None  0 
19S  1/20  0 
BPO-BGG  7S  None  34 
7S  1/20  0 
(T,G)-A--L  7S  None  0 
7S  1/20  0 
BPO-BGG  4S  None  32 
4S  1/20  0 
(T,G)-A--L  4S  None  10 
4S  1/20  3 
* The  %  inhibition  was  calculated  as  follows:  1  -  [(cpm  in  presence  of serum 
fraction)/cpm in presence of serum diluent (TBS)]  ×  100; see Materials and Meth- 
ods. 
13 guinea pigs, which had been immunized with either strain 2 or strain 13 anti- 
BPO-BGG, failed to form precipitating  antibodies as detected by double diffu- 
sion  in  1%  Ionagar  no.  2  (Difco  Laboratories)  even  when  the  antisera  were 
concentrated up to 10-fold and tested against a wide range of antigen (anti-BPO- 
BGG) concentrations. Furthermore, none of the antisera formed a precipitin line 
with BPO-BGG suggesting that no more than 0.1/~g of BPO-BGG (a quantity of 
BPO-BGG which when injected in CFA induces precipitating antibodies after 14 
days) could have been eluted from the antigen immunoadsorbent column during 
the preparation of anti-BPO-BGG. Table VII illustrates that strain 2 and strain 
13 anti-idiotypic sera bind isogeneic anti-BPO-BGG preferentially to the alloge- 
neic  antibody.  Furthermore,  the  binding  of isogeneic  125I-labeled  anti-BPO- 
BGG, on the other hand, by the anti-idiotypic serum immunoadsorbents can be 
inhibited by "cold" isogeneic anti-BPO-BGG to a slightly greater extent than by 
the allogeneic antibody. By contrast, Sepharose alone or Sepharose bearing 500 
~g of normal guinea pig Ig under these conditions, bind about 7,500 and 12,000 
cpm of labeled antibody, respectively. 
Does the Interaction of d Strain 2 and d Strain 13 BPO-BGG Sera with BPO- 
BGG-Sensitive Cells Result in the Liberation of Cytotoxic Factors or Immune 
Complexes which could Inhibit the Proliferation of Cells Sensitive to Another 
Antigen?  The inhibition  of antigen-induced  lymphocyte proliferation by anti- 
idiotypic  antisera  might  be  visualized  as  a  specific  blindfolding  of antigen 
receptors on T cells. However, it is also conceivable that the interaction of anti- 
idiotype antibodies with receptors might lead to the release of cytotoxic factors 
and/or immune complexes capable of nonspecifically blocking lymphocyte prolif- A.  F.  GECZY,  C.  L.  GECZY,  AND  A.  L.  de  WECK  235 
T~LE VII 
The Relative Affinity of Strain 2 and Strain 13 Anti-Idiotypic Sera for Isogeneic and 
A llogeneic A nti-BPO-BGG* 
Immunoadsorbent  Incubated with:  In the presence of:  Net* cpm bound by 
immunoadsorbent 
Sepharese-&  strain  2  *2SI-strain 2 anti-BPO-BGG  PBS  20,500 
BPO-BGG 
Sepharese-a  strain  13 
BPO-BGG 
~I-strain 2 anti-BPO-BGG  Strain 13 anti-BPO-BGG, 5 p-g  16,836 
~I-strain 2 anti-BPO-BGG  Strain 2 anti-BPO-BGG, 5 p-g  7,520 
L25I-strain 13 anti-BPO-BGG  PBS  10,024 
~2SI-strain 13 anti-BPO-BGG  Strain 2 anti-BPO-BGG, 5 p-g  6,641 
~I-strain 13 anti-BPO-BGG  Strain 13 anti-BPO-BGG, 5 pg  9,789 
~25I-strain 2 anti-BPO-BGG  PBS  5,810 
~2~I-strain 2 anti-BPO-BGG  Strain 13 anti-BPO-BGG, 5 p-g  3,803 
~2SI-strain 2 anti-BPO-BGG  Strain 2 anti-BPO-BGG, 5 p-g  5,686 
~l-strain 13 anti-BPO-BGG  PBS  15,031 
L~Sl-strain  13 anti-BPO-BGG  Strain 2 anti-BPO-BGG, 5 p-g  12,514 
~2~I-strain  13 anti-BPO-BGG  Strain 13 anti-BPO-BGG, 5/~g  7,075 
* Sepharose-~  strain 2 and ~ strain 13 immunoadsorbents (100 mg wet weight ofgal bearing 500 p.g of pretein, suspended in 100 p-l 
PBS) were incubated with 5 p-g ofradiolabeled antigen (Ig fractious of strain 2 and strain 13 anti-BFO-BGG) representing 5 × 106 
cpm  of labeled  protein,  in  the  presence  of PBS  or  unlabeled  antigen  (5  p.g). The  radioactivity bound  to  the  Sepharose 
immunoadsorbent was estimated as described in the Materials and Methods.  Results are expressed as counts per minute of 
triplicate determinations. 
* Net counts per minute are given by counts per minute of ~I-labeled anti-BPO.BGG bound by Sepharese-anti-idiotypic sera - 
counts per minute bound by Sepharose alone. 
eration. To test this possibility a portion (20 ×  106) of the primed (2 ×  13)F1 cells 
was pulsed simultaneously with BPO-BGG (400 fig) and (T,G)-A--L (400/~g),  see 
Materials  and  Methods.  The  antigen-pulsed  cells were then incubated  with 
normal guinea pig serum or anti-idiotypic sera. The suppression induced by the 
antisera in cell cultures which had been pulsed with both antigens was com- 
pared with the inhibition observed when the lymphoid cells were pulsed with 
each antigen separately.  The  data  in  Table  VHI  show that  the stimulation 
induced by BPO-BGG and (T,G)-A--L alone is not completely additive (cf. cells 
pulsed with both antigens simultaneously). However, the results clearly show 
that a  strain  13  and ~ strain  2 BPO-BGG sera do not completely inhibit the 
proliferation of cells which had been pulsed with both antigens and that stimu- 
lation by  (T,G)-A--L remains largely intact.  This suggests that inhibition  of 
proliferation  by  anti-idiotypic  sera  is  largely  specific  and  does  not  involve 
nonspecific cytotoxic cell  products,  which may be  released from BPO-BGG- 
sensitive cells, upon interaction with anti-idiotypic antibodies and/or antigen. 
Discussion 
There is a growing body of evidence that anti-idiotypic antibodies can specifi- 
cally regulate a  number of immunological phenomena such as the suppression 
(11-13)  or enhancement (14, 15) of antibody production and the specific inhibi- 
tion of graft-vs.-host (16, 17) and mixed leukocyte culture reactivity (18). In most 
instances anti-idiotypic antibodies were raised by allo- (17) or heteroimmuniza- 
tion  (14) though the production of autoanti-idiotypic antibodies has also been 
reported in rabbits  (19). The data presented in this paper clearly demonstrate 
that anti-idiotypic antibodies raised syngeneically in strain 2 and 13 guinea pigs 
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TABLE  VIII 
The Inhibition by Anti-Idiotypic Sera of  High Dose-Immunized (2 × 13)F, Lymph Node 
Cells Which Have Been Pulsed Simultaneously with BPO-BGG and (T,G)-A--L 
Guinea pig serum added* 
Stimulant  ~ Strain  a Strain 
Normal  13 Anti-2  2 Anti-13  2 BPO-BGG  13 BPO-BGG 
NIL  173"  183  205  267  235 
PHA  26,921  27,657  26,413  24,600  24,975 
BPO-BGG  14,002  14,494  28_.~8  354  290 
(T,G)-A--L  11,767  11,897  25____0  11,612  11,409 
BPO-BGG  +  20,507  20,993  254  11,934  8,838 
(T,G)-A--L 
* See footnote to Table I. 
cyte proliferation of cells from syngeneic guinea pigs. It is striking that in our 
system only the syngeneic strain produced an antiserum capable of inhibiting 
antigen-induced lymphocyte proliferation in that same strain, whereas alloim- 
munization was ineffective. No evidence was obtained that anti-idiotype or even 
antiallotype antibodies were produced by immunizing strain  2 animals  with 
anti-BPO-BGG antibodies from strain  13 and vice versa. This would suggest, 
that  strain  2  and  13  (which  are  closely related)  may  also  share  the  same 
immunoglobulin  allotypes.  On  the  other  hand,  our  findings  also  raise  the 
interesting notion that strain 2 and strain 13 guinea pigs are apparently high 
responders to  their own idiotypes but  not to  the  idiotypes of the  allogeneic 
strain.  This is consistent with the hypothesis that autoanti-idiotypes play an 
important role in the regulation of the immune response (20). We have previ- 
ously described the preparation of antisera which can specifically block antigen- 
induced lymphocyte proliferation (1). These antisera were raised by immunizing 
with lymphoid cells from various  (2  ×  13)F2 hybrid guinea pigs in which the 
responsiveness to low doses of ASAN,  BPO-BGG,  and  (T,G)-A--L segregated 
independently of each other.  One of these anti-R sera  (anti-RBeo-scc) closely 
resembles the strain 13 anti-idiotypic serum which has been raised by immuniz- 
ing strain 13 guinea pigs with immunoadsorbent-purified anti-BPO-BGG anti- 
body. The inhibitory activity of both sera, raised by these two different immuni- 
zation procedures, can be absorbed by lymphoid cells from immunized strain 13 
guinea pigs but not by cells from immunized strain 2 animals. The failure of 
nonimmunized strain 2 and strain 13 cells to absorb inhibitory activity suggests 
that immunization with BPO-BGG is necessary to stimulate the proliferation of 
sufficient clones of cells bearing specific receptors or recognition structures for 
BPO-BGG.  This view would also be consistent with the finding that antigen- 
specific receptors for phosphorylcholine on the surface of murine spleen cells are 
demonstrable on the cells of immunized but not of unimmunized animals (21). 
The anti-RBpo_acc serum and the strain 13 anti-idiotype serum can specifically 
inhibit BPO-BGG-induced T-cell stimulation and do not interfere with the in 
vitro proliferation of ASP-OVA-  and  (T,G)-A--L-pulsed lymphoid cells.  They 
seem therefore to interact specifically with BPO-BGG-specific lymphocyte recep- 
tors. It appears also that these antisera are not directed against gene products A.  F.  GECZY,  C.  L.  GECZY,  AND  A.  L.  de  WECK  237 
which are linked to or part of the 2 or the 13 MHC. Firstly, the antisera were 
raised either between 2 × 13 siblings (anti-RBeo-Bcc) or between inbred strain 13 
guinea pigs which should possess identical MHC. Secondly, neither antiserum 
inhibits  the  DNP-GL  or  GT  response  in  (2  x  13)F~ animals.  The  immune 
response to DNP-GL and GT is controlled by autosomal Ir genes linked to the 2 
and 13 MHC, respectively (7, 8). It view of the similarities in activity, specific- 
ity, and adsorption properties it is likely that anti-RBpo-Bcc and ~ strain 13 BPO- 
BGG are both directed against the same set of recognition structures for BPO- 
BGG on the cell membrane of strain 13 lymphocytes. Whether these recognition 
structures are represented to the same extent on T or B lymphocytes  will have to 
await immunofluorescence and autoradiographic studies.  Preliminary studies 
indicate that PEL are more efficient than lymph node cells in absorbing inhibi- 
tory activity from the anti-idiotypic sera suggesting that these idiotype recep- 
tors may be  expressed to a  greater extent on T  rather than on B  cells.  The 
observation that the anti-idiotypic antisera inhibited antigen-induced prolifera- 
tion of a purified T-cell population suggests the presence on T cells of receptors 
with similar idiotypic specificities to those present on circulating immunoglobu- 
lins. This would confirm the findings of Binz and Wigzell obtained with trans- 
plantation antigens (17). 
The inhibition of the BPO-BGG-induced response seems to involve an interac- 
tion between the antiserum and the appropriate strain-specific idiotype recep- 
tors on immune cells, i.e., a kind of blindfolding. The fact that inhibition occurs 
even after brief pulse with antigen but requires the continuous presence of the 
antibody during culture (1) is compatible with this interpretation. Furthermore, 
the failure of the BPO-BGG anti-idiotypic sera to completely inhibit a sensitive 
cell population which had been pulsed simultaneously with both BPO-BGG and 
(T,G)-A--L, suggests that the inhibition of BPO-BGG-sensitive cells is largely 
specific and that cytotoxic cell products or antigen-antibody complexes which 
may be released by BPO-BGG-sensitive cells are not able to suppress nonspecifi- 
cally  (T,G)-A--L-induced cell  proliferation.  It may be  wondered whether,  in 
addition to anti-idiotypic antibodies, the antisera raised by immunization with 
purified anti-BPO-BGG antibodies may also contain anti-BPO-BGG antibodies. 
This could theoretically be the case if BPO-BGG or immune complexes had been 
eluted from the immunoadsorbent column. However, if the animals, in addition 
to free anti-BPO-BGG antibody, had been immunized with a  small amount of 
eluted BPO-BGG-antibody complexes, it is difficult to see how the "contaminat- 
ing"  anti-BPO-BGG  in  the  anti-idiotype sera  could  account  for  the  specific 
inhibition of BPO-BGG-induced lymphocyte activation. Firstly, no such precipi- 
tating anti-BPO-BGG antibodies were detected in the anti-idiotype sera.  Sec- 
ondly, ~i strain 13 BPO-BGG totally inhibits the BPO-BGG response at a  final 
concentration of 1:100, whereas a  precipitating anti-BPO-BGG antiserum fails 
to do so at that concentration (data not shown). Anti-BPO-BGG even at a final 
concentration of 1:50 has virtually no effect on the PHA and antigen responses in 
vitro while a  strain 13  BPO-BGG at the same concentration totally abolishes 
antigen responsiveness. Finally, the possible presence of anti-BPO-BGG anti- 
bodies could not explain the strain-specific inhibitory effect of the anti-idiotypic 
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antibodies in the anti-idiotypic sera do not contribute to the inhibitory activity 
of these sera. 
The ability of both strain 2 and strain 13 anti-idiotypic sera to suppress BPO- 
BGG responsiveness of primed (2  x  13)F1 cells (Table I) could at first glance 
suggest that,  unlike the situation with immunoglobulin allotypes which fre- 
quently appear to display allelic exclusion (22, 23), both allelic forms of  the BPO- 
BGG-specific immunoglobulin idiotypes could be expressed on F1 lymphoid cells. 
However, this possibility holds for primed (2 × 13)F~ cells immunized with high 
doses of antigen (Table II). By contrast, (2 x  13)F1 cells primed with low doses of 
antigens are only inhibited by the ~ strain 13 BPO-BGG antiserum which also 
inhibits  immunized strain  13  (Table IV) cells but  not high dose-immunized 
strain 2 cells (Table III).  Accordingly, it is likely that strain 2 and 13 produce 
different sets of antibodies against BPO-BGG  with different idiotypic determi- 
nants.  Inhibition  of lymphocyte proliferation by  anti-idiotypic antibodies  is 
therefore likely to involve different clones of immune lymphoid cells.  Experi- 
ments on the heterogeneity of anti-BPO-BGG antibodies ate in progress. 
Preliminary evidence suggests that the inhibitory activity of the anti-idiotype 
sera is predominantly associated with the 19S fraction. It would appear there- 
fore that these antisera (even when obtained from animals 4 mo after immuniza- 
tion; results not shown) are IgM-like and in this respect perhaps similar to the 
anti-idiotypic antibody raised in Lewis  x  Brown Norway F1 rats immunized 
with Lewis anti-BN alloantibody (reference 23 and F. W. Fitch, personal com- 
munication). Our anti-idiotype sera appear therefore to differ from the anti- 
idiotypic antibodies of Eichmann (14) produced in guinea pigs against the A/J 
antibodies specific for the Group A streptococcal carbohydrate. The IgG~ fraction 
from the guinea pig anti-idiotypic serum injected into normal A/J mice can 
induce both T- and B-cell memory against the Group A streptococcal carbohy- 
drate and prime both T and B lymphocytes for a secondary immune response to 
this  antigen  (24). On the other hand,  guinea pig IgG2 can suppress in vivo 
antibody production to streptococcal carbohydrate in mice presumably by the 
elimination of specific precursor cells (14). 
Obviously, the production and specificity of anti-idiotypic antisera against the 
individual's own idiotypes (possibly functioning as antigen receptors) may have 
important implications for antigen recognition and the regulation of the im- 
mune response in vitro and possible also in vivo. Studies on the in vivo effects 
of these sera are currently in progress. 
Summary 
The in vitro T-cell proliferation induced by penicilloylated bovine IgG (BPO- 
BGG)  in  sensitized strain  2  and  strain  13  guinea pigs  could be  specifically 
blocked by strain-specific antisera presumably directed against cell membrane- 
associated immunoglobulin idiotypes. The anti-idiotypic antisera were prepared 
in strain 2 and strain 13 guinea pigs against immunoadsorbent purified anti- 
BPO-BGG antibodies which had been raised in strain 2 and strain 13 animals. 
Strain 13 antistrain 13 anti-BPO-BGG (4 strain 13 BPO-BGG) suppressed the in 
vitro BPO-BGG response of cells from immunized strain 13 animals but did not 
inhibit the response of cells from immune strain 2 animals.  Conversely, the A.  F.  GECZY,  C.  L.  GECZY,  AND  A.  L.  de  WECK  239 
corresponding antiserum raised in a strain 2 combination (4 strain 2 BPO-BGG) 
only inhibited the in vitro BPO-BGG response of strain 2 cells. Furthermore, the 
inhibitory activity of the antisera could only be absorbed by immune cells from 
the syngeneic strain. The activity of  the ~ strain 13 BPO-BGG serum was highly 
specific; the inhibitory activity could only be absorbed by BPO-BGG-sensitive 
strain 13 cells. The inhibitory activity of the anti-idiotypic sera was predomi- 
nantly associated with the 19S fraction. The data suggest that immune cells and 
in particular T  lymphocytes from strain 2 and strain  13  guinea pigs possess 
strain-specific recognition structures for BPO-BGG with the same idiotypes as 
the corresponding strain-specific immunoglobulins. Furthermore, the produc- 
tion of such inhibitory anti-idiotypic sera was restricted to syngeneic combina- 
tions,  which suggests a  potential role of autoanti-idiotypic antibodies in the 
regulation of the immune response.  The anti-idiotypic antisera used here are 
apparently directed against gene products not associated with the strain 2 or 
strain 13 major histocompatibility complex. 
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